Evidence map›Paper›PMID 27421959›Full record

ArticleBlood2016

Developing HSCs become Notch independent by the end of maturation in the AGM region.

Céline Souilhol, Javier G Lendinez, Stanislav Rybtsov, Fiona Murphy, Heather Wilson, David Hills, Antoniana Batsivari, Anahí Binagui-Casas, Alison C McGarvey, H Robson MacDonald and 4 more

Abstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. The evolving hematopoietic niche during development.Frontiers in molecular biosciences · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Hematopoietic Stem Cells and the Immune System in Development and Aging.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Céline SouilholInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Javier G LendinezInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Stanislav RybtsovInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Fiona MurphyInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Heather WilsonInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
David HillsInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Antoniana BatsivariInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Anahí Binagui-CasasInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Alison C McGarveyInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
H Robson MacDonaldLudwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland;
Ryoichiro KageyamaInstitute for Virus Research, University of Kyoto, Kyoto, Japan; and.
Christian SiebelDepartment of Discovery Oncology, Genentech, South San Francisco, CA.
Suling ZhaoInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;
Alexander MedvinskyInstitute for Stem Cell Research, Medical Research Council Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine Bioquarter, University of Edinburgh, Edinburgh, United Kingdom;

Funding

Biotechnology and Biological Sciences Research Council BB/D01347X/1Biotechnology and Biological Sciences Research Council BB/H008780/1Medical Research Council G0500950Medical Research Council G0900962Wellcome Trust
6 · The paper itself

Abstract

The first definitive hematopoietic stem cells (dHSCs) in the mouse emerge in the dorsal aorta of the embryonic day (E) 10.5 to 11 aorta-gonad-mesonephros (AGM) region. Notch signaling is essential for early HSC development but is dispensable for the maintenance of adult bone marrow HSCs. How Notch signaling regulates HSC formation in the embryo is poorly understood. We demonstrate here that Notch signaling is active in E10.5 HSC precursors and involves both Notch1 and Notch2 receptors, but is gradually downregulated while they progress toward dHSCs at E11.5. This downregulation is accompanied by gradual functional loss of Notch dependency. Thus, as early as at final steps in the AGM region, HSCs begin acquiring the Notch independency characteristic of adult bone marrow HSCs as part of the maturation program. Our data indicate that fine stage-dependent tuning of Notch signaling may be required for the generation of definitive HSCs from pluripotent cells.

Indexed as

AnimalsAortaCells, CulturedEmbryo, MammalianGonadsHematopoietic Stem CellsHematopoietic Stem Cell TransplantationMesonephrosMiceMice, Inbred C57BLMice, TransgenicReceptor, Notch2Signal TransductionStromal CellsReceptor, Notch2

Identifiers

PMID27421959
PMCPMC5034738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.